Hainan Honz Pharmaceutical Co (300086) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.009x

Based on the latest financial reports, Hainan Honz Pharmaceutical Co (300086) has a cash flow conversion efficiency ratio of -0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-9.17 Million ≈ $-1.34 Million USD) by net assets (CN¥1.07 Billion ≈ $157.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Hainan Honz Pharmaceutical Co to measure how many days the company can operate on defensive assets alone.

Hainan Honz Pharmaceutical Co - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Hainan Honz Pharmaceutical Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hainan Honz Pharmaceutical Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hainan Honz Pharmaceutical Co ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
HCM II Acquisition Corp NASDAQ:HOND	-0.002x
Costamare Bulkers Holdings Limited NYSE:CMDB	0.034x
Cogobuy Group F:7C3	-0.057x
Feedback Technology TWO:8091	0.017x
Binggrae KO:005180	0.154x
Shenzhen Mingdiao Decoration Co Ltd SHE:002830	0.043x
Norske Skog Asa OL:NSKOG	-0.052x
Zhejiang Realsun Chemical Co. Ltd. SHE:301212	N/A

Annual Cash Flow Conversion Efficiency for Hainan Honz Pharmaceutical Co (2007–2025)

The table below shows the annual cash flow conversion efficiency of Hainan Honz Pharmaceutical Co from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 300086 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥921.22 Million ≈ $134.80 Million	CN¥121.24 Million ≈ $17.74 Million	0.132x	+114.62%
2024-12-31	CN¥1.17 Billion ≈ $170.52 Million	CN¥71.46 Million ≈ $10.46 Million	0.061x	+19.53%
2023-12-31	CN¥1.38 Billion ≈ $201.65 Million	CN¥70.69 Million ≈ $10.34 Million	0.051x	+137.15%
2022-12-31	CN¥1.36 Billion ≈ $198.35 Million	CN¥29.32 Million ≈ $4.29 Million	0.022x	+196.65%
2021-12-31	CN¥1.55 Billion ≈ $227.35 Million	CN¥11.33 Million ≈ $1.66 Million	0.007x	+169.76%
2020-12-31	CN¥1.60 Billion ≈ $234.39 Million	CN¥-16.74 Million ≈ $-2.45 Million	-0.010x	-137.16%
2019-12-31	CN¥1.60 Billion ≈ $234.40 Million	CN¥45.06 Million ≈ $6.59 Million	0.028x	-70.50%
2018-12-31	CN¥1.65 Billion ≈ $241.97 Million	CN¥157.66 Million ≈ $23.07 Million	0.095x	+907.72%
2017-12-31	CN¥1.92 Billion ≈ $281.05 Million	CN¥18.17 Million ≈ $2.66 Million	0.009x	-80.51%
2016-12-31	CN¥1.87 Billion ≈ $274.03 Million	CN¥90.88 Million ≈ $13.30 Million	0.049x	+14.15%
2015-12-31	CN¥1.84 Billion ≈ $269.49 Million	CN¥78.30 Million ≈ $11.46 Million	0.043x	+3.78%
2014-12-31	CN¥1.80 Billion ≈ $264.07 Million	CN¥73.93 Million ≈ $10.82 Million	0.041x	-6.05%
2013-12-31	CN¥1.81 Billion ≈ $264.88 Million	CN¥78.93 Million ≈ $11.55 Million	0.044x	-25.37%
2012-12-31	CN¥1.87 Billion ≈ $274.16 Million	CN¥109.46 Million ≈ $16.02 Million	0.058x	+207.30%
2011-12-31	CN¥1.85 Billion ≈ $271.29 Million	CN¥-100.94 Million ≈ $-14.77 Million	-0.054x	-224.62%
2010-12-31	CN¥1.83 Billion ≈ $267.58 Million	CN¥79.89 Million ≈ $11.69 Million	0.044x	-88.77%
2009-12-31	CN¥240.49 Million ≈ $35.19 Million	CN¥93.58 Million ≈ $13.69 Million	0.389x	-6.52%
2008-12-31	CN¥150.41 Million ≈ $22.01 Million	CN¥62.61 Million ≈ $9.16 Million	0.416x	+57.69%
2007-12-31	CN¥115.89 Million ≈ $16.96 Million	CN¥30.59 Million ≈ $4.48 Million	0.264x	--

About Hainan Honz Pharmaceutical Co

SHE:300086 China Drug Manufacturers - Specialty & Generic

Market Cap

$414.91 Million

CN¥2.84 Billion CNY

Market Cap Rank

#13393 Global

#4035 in China

Share Price

CN¥6.23

Change (1 day)

+0.65%

52-Week Range

CN¥5.06 - CN¥13.71

All Time High

CN¥17.75